Brendan O’Grady, Executive Vice President – North America Commercial, has submitted his resignation from Teva, effective August 15, 2021, in order to pursue other career opportunities.
Key facts
Extracted from this filing and checked against the source text.
Executive changeSEC 8-K Item 5.02confidence 0.95
Brendan O’Grady resigned as Executive Vice President – North America Commercial at TEVA PHARMACEUTICAL INDUSTRIES LTD.
Action
resigned
Role
Executive Vice President – North America Commercial
Exact text from the filing
Brendan O’Grady, Executive Vice President – North America Commercial, has submitted his resignation from Teva, effective August 15, 2021, in order to pursue other career opportunities.
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.